Clinical Trial Update: ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Ongoing Phase 1 clinical trial ARTEMIS-102 evaluating HS-20093 combinations in patients with advanced metastatic colorectal cancer; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HS-20093

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 1 | Status: RECRUITING